Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 197

Similar articles for PubMed (Select 4797465)

1.

The effect of lowering the serum phosphate on parathyroid hormone secretion and total serum calcium during regular hemodialysis.

Hill AV, Thein-Than, Cook DB, Derr KN, Latner AL.

Clin Nephrol. 1973 Sep-Oct;1(5):284-9. No abstract available.

PMID:
4797465
2.

Impact of calcium, phosphate, PTH abnormalities and management on mortality in hemodialysis: results from the RISCAVID study.

Panichi V, Bigazzi R, Paoletti S, Mantuano E, Beati S, Marchetti V, Bernabini G, Grazi G, Giust R, Rosati A, Migliori M, Pasquariello A, Panicucci E, Barsotti G, Bellasi A; RISCAVID Study Group.

J Nephrol. 2010 Sep-Oct;23(5):556-62.

PMID:
20349412
3.

Development and utility of a multi-dimensional grid to assess individual mineral metabolism control in hemodialysis patients: A potential aid for therapeutic decision making?

Morton AR, Murphy S, Hirsch D, Leblanc M, Barré P, Lok C, Hercz G, Hodsman A, Reslerova M, Levin A.

Hemodial Int. 2010 Apr;14(2):200-10. doi: 10.1111/j.1542-4758.2009.00426.x. Epub 2010 Mar 12.

PMID:
20337745
4.

Sudden cardiac death and mineral metabolism in chronic kidney disease.

Afsar B, Elsurer R.

Kidney Int. 2010 Apr;77(7):648; author reply 648-9. doi: 10.1038/ki.2009.527. No abstract available.

PMID:
20224591
6.

Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients.

Hwang JC, Chen CA, Wang CT, Chen HC.

Ren Fail. 2008;30(10):943-51. doi: 10.1080/08860220802516563.

PMID:
19016144
7.

Evaluation of a phosphate management protocol to achieve optimum serum phosphate levels in hemodialysis patients.

Yokum D, Glass G, Cheung CF, Cunningham J, Fan S, Madden AM.

J Ren Nutr. 2008 Nov;18(6):521-9. doi: 10.1053/j.jrn.2008.05.003.

PMID:
18940656
8.

Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients.

Courbebaisse M, Thervet E, Souberbielle JC, Zuber J, Eladari D, Martinez F, Mamzer-Bruneel MF, Urena P, Legendre C, Friedlander G, Prié D.

Kidney Int. 2009 Mar;75(6):646-51. doi: 10.1038/ki.2008.549. Epub 2008 Oct 15.

PMID:
18923386
9.

Pulmonary hypertension in hemodialysis patients.

Mahdavi-Mazdeh M, Alijavad-Mousavi S, Yahyazadeh H, Azadi M, Yoosefnejad H, Ataiipoor Y.

Saudi J Kidney Dis Transpl. 2008 Mar;19(2):189-93.

10.

Effect of sevelamer on mineral and lipid abnormalities in hemodialysis patients.

Hamida FB, Fatma LB, Barbouch S, Kaaroud H, Helal I, Hedri H, Abdallah TB, Maiz HB, Kheder A.

Saudi J Kidney Dis Transpl. 2008 Mar;19(2):183-8.

11.

Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.

Mazzaferro S, Pasquali M, Farcomeni A, Vestri AR, Filippini A, Romani AM, Barresi G, Pugliese F.

Nephrol Dial Transplant. 2008 Jul;23(7):2319-23. doi: 10.1093/ndt/gfm931. Epub 2008 Feb 15.

12.

Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis.

Shigematsu T; Lanthanum Carbonate Research Group.

Ther Apher Dial. 2008 Feb;12(1):55-61. doi: 10.1111/j.1744-9987.2007.00541.x.

PMID:
18257813
13.

Residual renal function plays an important role in regulating parathyroid hormone in patients on continuous ambulatory peritoneal dialysis.

Okada S, Inoue T, Nakamoto H, Ikeda N, Sugahara S, Shoda J, Okada H, Kanno Y, Suzuki H.

Adv Perit Dial. 2007;23:150-4.

PMID:
17886623
14.
15.

Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure.

Hostutler RA, DiBartola SP, Chew DJ, Nagode LA, Schenck PA, Rajala-Schultz PJ, Drost WT.

J Vet Intern Med. 2006 Nov-Dec;20(6):1307-13.

PMID:
17186842
16.

K/DOQI guideline requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them?

Wei M, Taskapan H, Esbaei K, Jassal SV, Bargman JM, Oreopoulos DG.

Int Urol Nephrol. 2006;38(3-4):739-43. Epub 2006 Dec 11.

PMID:
17160632
17.

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.

Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ, Powe NR.

Kidney Int. 2006 Jul;70(2):351-7. Epub 2006 May 31.

PMID:
16738536
18.

Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.

Avila-Díaz M, Matos M, García-López E, Prado MD, Castro-Vázquez F, Ventura MD, González E, Amato D, Paniagua R.

Perit Dial Int. 2006 Jan-Feb;26(1):78-84.

19.

Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.

Oyama Y, Kazama JJ, Omori K, Higuchi N, Kameda S, Yamamoto S, Ito Y, Maruyama H, Narita I, Gejyo F.

Clin Exp Nephrol. 2005 Jun;9(2):142-7.

PMID:
15980949
20.

Different routes bridging calcium in Japanese hemodialysis patients.

Hamano T, Fujii N, Ito T, Imai E.

Ther Apher Dial. 2005 Feb;9(1):32-8.

PMID:
15828903
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk